Thomas Bryrup

771 total citations · 1 hit paper
10 papers, 595 citations indexed

About

Thomas Bryrup is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Thomas Bryrup has authored 10 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 2 papers in Physiology. Recurrent topics in Thomas Bryrup's work include Cystic Fibrosis Research Advances (6 papers), Neonatal Respiratory Health Research (4 papers) and Gut microbiota and health (3 papers). Thomas Bryrup is often cited by papers focused on Cystic Fibrosis Research Advances (6 papers), Neonatal Respiratory Health Research (4 papers) and Gut microbiota and health (3 papers). Thomas Bryrup collaborates with scholars based in Denmark and United Kingdom. Thomas Bryrup's co-authors include Oluf Pedersen, Tue H. Hansen, Trine Nielsen, Kristine H. Allin, Niklas Rye Jørgensen, Torben Hansen, Henrik Vestergaard, Ivan Brandslund, Søren Jensen‐Fangel and Tavs Qvist and has published in prestigious journals such as Diabetologia, Genome Medicine and Pediatric Pulmonology.

In The Last Decade

Thomas Bryrup

5 papers receiving 584 citations

Hit Papers

Alterations in fecal microbiota composition by probiotic ... 2016 2026 2019 2022 2016 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Bryrup Denmark 4 469 189 159 128 80 10 595
Patrycja Konieczna Switzerland 9 361 0.8× 144 0.8× 152 1.0× 91 0.7× 79 1.0× 14 672
Vera Carvalho Denmark 3 539 1.1× 196 1.0× 95 0.6× 162 1.3× 96 1.2× 4 676
Heena Buch China 6 480 1.0× 127 0.7× 120 0.8× 152 1.2× 54 0.7× 7 643
Anissa M. Armet Canada 6 529 1.1× 262 1.4× 104 0.7× 118 0.9× 46 0.6× 9 725
S Deleu Belgium 6 430 0.9× 148 0.8× 112 0.7× 100 0.8× 63 0.8× 18 617
Anna Popenko Russia 12 536 1.1× 260 1.4× 91 0.6× 102 0.8× 44 0.6× 26 699
Hanne Jouhten Finland 4 400 0.9× 128 0.7× 88 0.6× 161 1.3× 88 1.1× 4 580
Yoshiki Tanaka Japan 15 366 0.8× 130 0.7× 105 0.7× 106 0.8× 106 1.3× 31 609
Aki Ronkainen Finland 5 334 0.7× 121 0.6× 94 0.6× 76 0.6× 55 0.7× 8 493
Costantino Dargenio Italy 6 372 0.8× 122 0.6× 211 1.3× 65 0.5× 76 0.9× 11 654

Countries citing papers authored by Thomas Bryrup

Since Specialization
Citations

This map shows the geographic impact of Thomas Bryrup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Bryrup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Bryrup more than expected).

Fields of papers citing papers by Thomas Bryrup

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Bryrup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Bryrup. The network helps show where Thomas Bryrup may publish in the future.

Co-authorship network of co-authors of Thomas Bryrup

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Bryrup. A scholar is included among the top collaborators of Thomas Bryrup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Bryrup. Thomas Bryrup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Olsen, Mette Frahm, Daniel Faurholt‐Jepsen, Marianne Hørby Jørgensen, et al.. (2025). Severe hepatotoxicity is uncommon following the introduction of Elexacaftor/Tezacaftor/Ivacaftor: A real-world two-years follow-up study of the Danish cystic fibrosis cohort. Journal of Cystic Fibrosis. 24(5). 998–1005.
2.
Lyu, Liwei, Yong Fan, Thomas Bryrup, et al.. (2025). Glucocorticoid-induced changes of the gut microbiota and metabolic markers in healthy young men: Outcome of a randomized controlled trial. Cell Reports Medicine. 6(11). 102426–102426.
3.
Olsen, Mette Frahm, Tacjana Pressler, Thomas Bryrup, et al.. (2025). Real‐World Improvements of Lung Clearance Index and Ventilation Distribution Efficiency in Children With Cystic Fibrosis After Elexacaftor/Tezacaftor/Ivacaftor Initiation. Pediatric Pulmonology. 60(6). e71166–e71166.
5.
Faurholt‐Jepsen, Daniel, et al.. (2024). Improved early growth in Danish children with cystic fibrosis from 2000-2022. Journal of Cystic Fibrosis. 23(4). 764–770.
6.
Faurholt‐Jepsen, Daniel, Tavs Qvist, Bibi Uhre Nielsen, et al.. (2024). Lung function improvement on triple modulators: high-resolution, nationwide data from the Danish Cystic Fibrosis Cohort. ERJ Open Research. 10(6). 339–2024. 5 indexed citations
7.
Bryrup, Thomas, Daniel Faurholt‐Jepsen, Tacjana Pressler, et al.. (2024). Real‐world data confirm elexacftor/tezacaftor/ivacaftor modulators halves sweat chloride concentration in eligible people with cystic fibrosis. Apmis. 132(10). 728–733. 8 indexed citations
8.
Krarup, Nikolaj T., Thomas Bryrup, Julie Støy, et al.. (2022). The Arg82Cys Polymorphism of the Protein Nepmucin Implies a Role in HDL Metabolism. Journal of the Endocrine Society. 6(5). bvac034–bvac034. 2 indexed citations
9.
Bryrup, Thomas, Kristine H. Allin, Ivan Brandslund, et al.. (2019). Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study. Diabetologia. 62(6). 1024–1035. 157 indexed citations
10.
Bryrup, Thomas, et al.. (2016). Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Medicine. 8(1). 52–52. 423 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026